Aminoglycoside research 1975-1985: prospects for development of improved agents.
作者信息
Price K E
出版信息
Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. doi: 10.1128/AAC.29.4.543.
Abstract
摘要
相似文献
1
Aminoglycoside research 1975-1985: prospects for development of improved agents.1975 - 1985年氨基糖苷类药物研究：改进型药物的开发前景
Antimicrob Agents Chemother. 1986 Apr;29(4):543-8. doi: 10.1128/AAC.29.4.543.
2
A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.美国成人囊性纤维化治疗项目中延长给药间隔氨基糖苷类药物给药实践的调查。
Respir Care. 2014 Sep;59(9):1353-9. doi: 10.4187/respcare.02980. Epub 2014 Apr 29.
3
[The pharmacokinetic interpretation of the nephrotoxic effect of aminoglycosides and the influence of cephalosporins on the aminoglycoside nephrotoxic effect].
Antibiot Khimioter. 1989 Dec;34(12):920-5.
4
Aminoglycoside therapy. Current use and future prospects.氨基糖苷类药物治疗：当前应用与未来前景
Pharm Weekbl Sci. 1990 Jun 22;12(3):81-90. doi: 10.1007/BF01967600.
5
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.泊沙康唑：一种新型氨基糖苷类药物，用于治疗耐药革兰氏阴性菌感染。
Drugs. 2019 Feb;79(3):243-269. doi: 10.1007/s40265-019-1054-3.
6
Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.重新评估当代药代动力学和药效学原则以指导氨基糖苷类药物的给药。
Pharmacotherapy. 2018 Dec;38(12):1229-1238. doi: 10.1002/phar.2193.
7
[Value of aminoglycoside antibiotics in the therapy of bacterial infections].[氨基糖苷类抗生素在细菌感染治疗中的价值]
Med Klin (Munich). 1993 Jul 15;88(7):438-44.
8
[Aminoglycoside single or multiple daily doses?].
Ugeskr Laeger. 1993 Dec 20;155(51):4192-4.
9
[Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
Yakugaku Zasshi. 2006 May;126(5):327-35. doi: 10.1248/yakushi.126.327.
10
Aminoglycoside-induced ototoxicity.氨基糖苷类药物所致耳毒性
Curr Pharm Des. 2007;13(1):119-26. doi: 10.2174/138161207779313731.
引用本文的文献
1
Once-daily aminoglycoside dosing: A new look at an old drug.每日一次氨基糖苷类药物给药：对一种老药的新审视。
Can J Infect Dis. 1994 Sep;5(5):205-6. doi: 10.1155/1994/796138.
2
Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.氨基糖苷类耳毒性的机制及毛细胞保护靶点。
Int J Otolaryngol. 2011;2011:937861. doi: 10.1155/2011/937861. Epub 2011 Oct 25.
3
Aminoglycosides: nephrotoxicity.氨基糖苷类：肾毒性。
Antimicrob Agents Chemother. 1999 May;43(5):1003-12. doi: 10.1128/AAC.43.5.1003.
4
Aminoglycosides: activity and resistance.氨基糖苷类：活性与耐药性。
Antimicrob Agents Chemother. 1999 Apr;43(4):727-37. doi: 10.1128/AAC.43.4.727.
5
Bacterial resistance after in vitro exposure to amikacin and netilmicin.体外暴露于阿米卡星和奈替米星后的细菌耐药性。
Eur J Clin Microbiol. 1986 Aug;5(4):456-8. doi: 10.1007/BF02075708.
6
Enhanced gentamicin killing of Escherichia coli by tet gene expression.tet基因表达增强庆大霉素对大肠杆菌的杀伤作用。
Antimicrob Agents Chemother. 1989 Feb;33(2):230-2. doi: 10.1128/AAC.33.2.230.
7
In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.新型假二糖氨基糖苷类药物达替米星的体外活性与其他氨基糖苷类药物活性的比较。
Antimicrob Agents Chemother. 1989 Nov;33(11):1998-2003. doi: 10.1128/AAC.33.11.1998.
8
Once-daily aminoglycoside administration: new strategies for an old drug.每日一次氨基糖苷类药物给药：老药新策略
Eur J Clin Microbiol Infect Dis. 1989 Sep;8(9):761-9. doi: 10.1007/BF02185842.
9
Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):639-43. doi: 10.1007/BF01968148.
10
Discovery and development of new antimicrobial agents.新型抗菌药物的发现与研发。
Clin Microbiol Rev. 1990 Jan;3(1):13-31. doi: 10.1128/CMR.3.1.13.
本文引用的文献
1
GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA.庆大霉素，一种来自小单孢菌属的新型抗生素复合物。
J Med Chem. 1963 Jul;6:463-4. doi: 10.1021/jm00340a034.
2
Production and isolation of a new antibiotic: kanamycin.一种新型抗生素——卡那霉素的生产与分离
J Antibiot (Tokyo). 1957 Sep;10(5):181-8.
3
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.化合物A49759，福提霉素A的3-O-去甲基衍生物：与其他六种氨基糖苷类抗生素的体外比较
Antimicrob Agents Chemother. 1980 Nov;18(5):773-9. doi: 10.1128/AAC.18.5.773.
4
Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.福提霉素A的衍生物O-去甲基福提霉素A的抗菌活性比较
Antimicrob Agents Chemother. 1980 Nov;18(5):766-72. doi: 10.1128/AAC.18.5.766.
5
Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats.高剂量奈替米星和妥布霉素对大鼠的肾毒性比较
Antimicrob Agents Chemother. 1980 Aug;18(2):346-8. doi: 10.1128/AAC.18.2.346.
6
Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.庆大霉素、妥布霉素和阿米卡星的低剂量肾毒性比较
Antimicrob Agents Chemother. 1980 Jul;18(1):176-81. doi: 10.1128/AAC.18.1.176.
7
Acute and subacute toxicity studies with fortimicin A sulfate (Abbott-44747), a new aminoglycoside antibiotic.硫酸福提米星A（雅培-44747），一种新型氨基糖苷类抗生素的急性和亚急性毒性研究。
Toxicol Appl Pharmacol. 1980 May;53(3):399-409. doi: 10.1016/0041-008x(80)90353-1.
8
Nonparallel nephrotoxicity dose-response curves of aminoglycosides.氨基糖苷类药物的非平行肾毒性剂量反应曲线。
Antimicrob Agents Chemother. 1981 Jun;19(6):1024-8. doi: 10.1128/AAC.19.6.1024.
9
Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.奈替米星与阿米卡星疗效及毒性的前瞻性对照研究
Antimicrob Agents Chemother. 1980 Feb;17(2):217-25. doi: 10.1128/AAC.17.2.217.
10
Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.长期使用阿米卡星。对革兰氏阴性杆菌氨基糖苷类药物敏感性模式的影响。
JAMA. 1982 Sep 10;248(10):1199-202. doi: 10.1001/jama.248.10.1199.
Zotero 插件